American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Natixis Advisors L.P. Acquires 5,318 Shares of Vanguard International High Dividend Yield ETF (NASDAQ:VYMI)

Natixis Advisors L.P. Acquires 5,318 Shares of Vanguard International High Dividend Yield ETF (NASDAQ:VYMI)

Natixis Advisors L.P. increased its holdings in Vanguard International High Dividend Yield ETF (NASDAQ:VYMI – Free Report) by 16.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities... More of this article »
Image about Natixis Advisors L.P. Decreases Stake in RenaissanceRe Holdings Ltd. (NYSE:RNR)

Natixis Advisors L.P. Decreases Stake in RenaissanceRe Holdings Ltd. (NYSE:RNR)

Natixis Advisors L.P. reduced its position in RenaissanceRe Holdings Ltd. (NYSE:RNR – Free Report) by 16.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 12,526 shares of the... More of this article »
Image about Natixis Advisors L.P. Has $2.50 Million Stock Position in United Airlines Holdings, Inc. (NASDAQ:UAL)

Natixis Advisors L.P. Has $2.50 Million Stock Position in United Airlines Holdings, Inc. (NASDAQ:UAL)

Natixis Advisors L.P. cut its position in shares of United Airlines Holdings, Inc. (NASDAQ:UAL – Free Report) by 17.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission.... More of this article »
Image about Boot Barn Holdings, Inc. (NYSE:BOOT) Shares Bought by Natixis Advisors L.P.

Boot Barn Holdings, Inc. (NYSE:BOOT) Shares Bought by Natixis Advisors L.P.

Natixis Advisors L.P. lifted its stake in shares of Boot Barn Holdings, Inc. (NYSE:BOOT – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).... More of this article »
Image about Natixis Advisors L.P. Purchases 4,072 Shares of FMC Co. (NYSE:FMC)

Natixis Advisors L.P. Purchases 4,072 Shares of FMC Co. (NYSE:FMC)

Natixis Advisors L.P. increased its holdings in FMC Co. (NYSE:FMC – Free Report) by 11.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned... More of this article »
Image about Natixis Advisors L.P. Grows Stock Position in Essential Properties Realty Trust, Inc. (NYSE:EPRT)

Natixis Advisors L.P. Grows Stock Position in Essential Properties Realty Trust, Inc. (NYSE:EPRT)

Natixis Advisors L.P. boosted its stake in shares of Essential Properties Realty Trust, Inc. (NYSE:EPRT – Free Report) by 20.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission... More of this article »
Image about Swiss National Bank Cuts Position in Insperity, Inc. (NYSE:NSP)

Swiss National Bank Cuts Position in Insperity, Inc. (NYSE:NSP)

Swiss National Bank lowered its holdings in Insperity, Inc. (NYSE:NSP – Free Report) by 10.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 71,500 shares of the business... More of this article »
Image about Swiss National Bank Sells 45,300 Shares of Huntsman Co. (NYSE:HUN)

Swiss National Bank Sells 45,300 Shares of Huntsman Co. (NYSE:HUN)

Swiss National Bank reduced its position in shares of Huntsman Co. (NYSE:HUN – Free Report) by 12.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 333,074... More of this article »
Image about Swiss National Bank Sells 15,400 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Swiss National Bank Sells 15,400 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH)

Swiss National Bank trimmed its position in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 10.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.... More of this article »
Image about Recursion Pharmaceuticals’ (RXRX) Buy Rating Reiterated at Needham & Company LLC

Recursion Pharmaceuticals’ (RXRX) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) in a report issued on Friday morning, Benzinga reports. Needham & Company LLC currently has a $17.00... More of this article »
Image about FIGS (NYSE:FIGS) Earns “Market Perform” Rating from Telsey Advisory Group

FIGS (NYSE:FIGS) Earns “Market Perform” Rating from Telsey Advisory Group

Telsey Advisory Group restated their market perform rating on shares of FIGS (NYSE:FIGS – Free Report) in a research report sent to investors on Friday, Benzinga reports. They currently have a $6.00 price target on the stock. A... More of this article »
Image about Revance Therapeutics (NASDAQ:RVNC) Rating Reiterated by Piper Sandler

Revance Therapeutics (NASDAQ:RVNC) Rating Reiterated by Piper Sandler

Piper Sandler reiterated their overweight rating on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research note released on Friday morning, Benzinga reports. Piper Sandler currently has a $11.00 price objective... More of this article »
Image about Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Sold by Swiss National Bank

Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Sold by Swiss National Bank

Swiss National Bank cut its stake in Silicon Laboratories Inc. (NASDAQ:SLAB – Free Report) by 10.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The... More of this article »
Image about Swiss National Bank Has $8.39 Million Holdings in Concentrix Co. (NASDAQ:CNXC)

Swiss National Bank Has $8.39 Million Holdings in Concentrix Co. (NASDAQ:CNXC)

Swiss National Bank trimmed its holdings in Concentrix Co. (NASDAQ:CNXC – Free Report) by 12.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.... More of this article »
Image about STERIS’s (STE) Neutral Rating Reiterated at Piper Sandler

STERIS’s (STE) Neutral Rating Reiterated at Piper Sandler

Piper Sandler reaffirmed their neutral rating on shares of STERIS (NYSE:STE – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. Piper Sandler currently has a $225.00 price objective on... More of this article »